Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» asthma
asthma
Novartis' asthma triplet beats GSK's Advair in phase 2 trial
Fierce Pharma
Wed, 05/22/19 - 10:51 am
Novartis
asthma
QVM149
GSK
Advair
clinical trials
AstraZeneca says Symbicort as anti-inflammatory reliever reduces attacks in mild asthma
Pharmaceutical Business Review
Tue, 05/21/19 - 10:41 am
AstraZeneca
Symbicort Turbohaler
asthma
mild asthma
AstraZeneca's Fasenra offers severe asthma patients 2 years of benefits: analysis
Fierce Pharma
Mon, 05/20/19 - 10:12 am
AstraZeneca
Fasenra
severe asthma
asthma
clinical trials
Trial could unlock asthma use for GSK’s Trelegy
Pharmaforum
Fri, 05/3/19 - 10:17 am
GSK
Trelegy
COPD
asthma
Research Roundup: New CRISPR, ALS, Colon Cancer, Asthma and More
BioSpace
Sun, 04/21/19 - 10:35 pm
CRISPR
gene editing
asthma
colon cancer
ALS
AstraZeneca’s asthma drug Fasenra looks promising for a set of rare chronic immune diseases
Endpoints
Thu, 04/4/19 - 10:30 am
AstraZeneca
Fasenra
asthma
HES
FDA
130 medicines in development for asthma, allergies and other respiratory diseases
PhRMA
Thu, 02/21/19 - 11:02 pm
allergies
asthma
respiratory disease
drug development
Propeller, Orion to develop digital asthma, COPD therapy
Drug Delivery Business News
Mon, 02/11/19 - 08:07 pm
Propeller Health
devices
Orion
asthma
COPD
Easyhaler
Pulmatrix wins FDA nod for PhII trial of inhaled anti-fungal therapy
Drug Delivery Business News
Thu, 02/7/19 - 11:24 pm
Pulmatrix
FDA
anti-fungal
itraconazole
asthma
allergic bronchopulmonatry aspergillosis
Mylan’s Generic Advair Breathes New Life into Asthma Market
Xtalks
Tue, 02/5/19 - 10:03 am
Mylan
GSK
Advair
generics
FDA
asthma
Wixela Inhub
FDA approves Teva’s digital COPD, asthma inhaler
Drug Delivery Business News
Wed, 12/26/18 - 04:40 pm
Teva Pharmaceutical
ProAir Digihaler
devices
asthma
COPD
FDA
AstraZeneca divests asthma and rhinitis drug rights to Covis Pharma
Pharmaceutical Business Review
Thu, 12/6/18 - 11:33 pm
AstraZeneca
Covis Pharma
asthma
Sanofi merges biology and tech with research deal for digital asthma lab
Fierce Pharma
Wed, 12/5/18 - 09:59 am
Sanofi
asthma
artificial intelligence
technology
Sema4
Asthma Drug Co-Developed by Dynavax and AstraZeneca Fails to Meet Endpoints in Phase IIa Trial
BioSpace
Fri, 11/30/18 - 10:20 am
asthma
Dynavax
AstraZeneca
clinical trials
AZD1419
4 Ways In Which AI Is Revolutionizing Respiratory Care
Forbes
Mon, 11/26/18 - 11:31 pm
devices
artificial intelligence
asthma
COPD
respiratory health
AstraZeneca Unloads Three Asthma and Rhinitis Drugs to Covis Pharma for $350 Million
BioSpace
Tue, 11/6/18 - 11:46 am
AstraZeneca
asthma
rhinitis
Covis Pharma
Alvesco
Omnaris
Zetonna
Sanofi drug Dupixent wins U.S. FDA approval to treat asthma
Yahoo/Reuters
Fri, 10/19/18 - 10:49 pm
Sanofi
asthma
FDA
Dupixent
AstraZeneca, shut out of COPD, touts long-term Fasenra asthma data
Fierce Pharma
Tue, 09/18/18 - 10:13 pm
AstraZeneca
COPD
Fasenra
asthma
GSK touts Nucala data after COPD miss
Biopharma Dive
Tue, 09/11/18 - 11:55 am
GSK
asthma
COPD
Nucala
EC approves GSK's Nucala for kids with severe asthma
Biopharma Dive
Fri, 08/31/18 - 11:51 pm
GSK
Nucala
Europe
asthma
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »